| Literature DB >> 31899839 |
Sophie Vichier-Guerre1, Therese C Ku2, Sylvie Pochet1, Katherine L Seley-Radtke2.
Abstract
The structurally unique "fleximer" nucleosides were originally designed to investigate how flexibility in a nucleobase could potentially affect receptor-ligand recognition and function. Recently they have been shown to have low-to-sub-micromolar levels of activity against a number of viruses, including coronaviruses, filoviruses, and flaviviruses. However, the synthesis of distal fleximers in particular has thus far been quite tedious and low yielding. As a potential solution to this issue, a series of proximal fleximer bases (flex-bases) has been successfully coupled to both ribose and 2'-deoxyribose sugars by using the N-deoxyribosyltransferase II of Lactobacillus leichmannii (LlNDT) and Escherichia coli purine nucleoside phosphorylase (PNP). To explore the range of this facile approach, transglycosylation experiments on a thieno-expanded tricyclic heterocyclic base, as well as several distal and proximal flex-bases were performed to determine whether the corresponding fleximer nucleosides could be obtained in this fashion, thus potentially significantly shortening the route to these biologically significant compounds. The results of those studies are reported herein.Entities:
Keywords: biocatalysis; deoxyribosyltransferase; fleximers; nucleosides; purine nucleoside phosphorylase
Mesh:
Substances:
Year: 2020 PMID: 31899839 PMCID: PMC7228337 DOI: 10.1002/cbic.201900714
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.461
Figure 1Seley‐Radtke's guanosine fleximers.
Scheme 1Enzymatic transglycosylation of proximal fleximers.42, 43.
Figure 2Flex‐ and tricyclic bases used for transglycosylation.
Transglycosylation reactions of flex‐bases (1–5) catalyzed by LlNDT.[a]
|
|
Acceptor |
|
Incubation |
Product [%][b] | ||
|---|---|---|---|---|---|---|
|
|
|
[μL] |
time [h] |
Starting |
N1‐glycosylated |
N3‐glycosylated |
|
|
|
|
|
material |
product |
product |
|
1 |
|
1.25 |
3 |
61 |
17 |
22 |
|
2 |
1.25 |
10 |
53 |
28 |
20 | |
|
3 |
2.5 |
3 |
40 |
74 |
13 | |
|
4 |
2.5 |
10 |
24 |
65 |
6 | |
|
5 |
5.0 |
3 |
15 |
80 |
5 | |
|
6 |
5.0 |
10 |
10 |
88 |
2 | |
|
7 |
7.5 |
3 |
12 |
86 |
2 | |
|
8 |
7.5 |
10 |
10 |
89 |
1 | |
|
9 |
10.0 |
3 |
11 |
87 |
2 | |
|
10 |
10.0 |
10 |
10 |
89 |
1 | |
|
11 |
|
1.25 |
3 |
24 |
30 |
46 |
|
12 |
1.25 |
10 |
17 |
45 |
38 | |
|
13 |
2.5 |
3 |
18 |
42 |
40 | |
|
14 |
2.5 |
10 |
10 |
78 |
12 | |
|
15 |
|
1.25 |
3 |
70 |
30 |
– |
|
16 |
1.25 |
10 |
20 |
80 |
– | |
|
17 |
2.5 |
3 |
7 |
93 |
– | |
|
18 |
2.5 |
10 |
4 |
96 |
– | |
|
19 |
|
1.25 |
0.5 |
0 |
100 |
– |
|
20 |
0.63 |
0.5 |
18 |
82 |
– | |
|
21 |
0.15 |
3 |
40 |
60 |
– | |
|
22 |
|
1.25 |
3 |
2 |
62 and 32c |
4 |
|
23 |
1.25 |
10 |
2 |
46 and 44c |
6 | |
|
24 |
0.63 |
3 |
3 |
71 and 23c |
3 | |
|
25 |
0.63 |
10 |
2 |
58 and 34c |
6 | |
[a] Reaction conditions: 1 μmol acceptor in 5 % v/v DMSO, 4 μmol thymidine in 10 mm citrate buffer (pH 6.5; 0.1 mL) in the presence of LlNDT at 37 °C. [b] Percentage conversion was determined by reversed‐phase HPLC analysis of an aliquot of the incubation mixture monitored at 254 nm. [c] Product from glycosylation at both imidazole and pyrimidine nitrogens of 5.
Scheme 2NDT‐catalyzed transglycosylation of flex‐bases 1–4.
Scheme 3NDT‐catalyzed transglycosylation of flex‐base 5.
Figure 3HPLC analysis at t=0, 3 h and 16 h of the transglycosylation reaction of 5 in the presence of thymidine (4 equiv) and NDT (0.63 μL/μmol acceptor) at 37 °C. HPLC conditions: 0–20 % linear gradient of acetonitrile in 10 mm TEAA buffer (pH 6.0) over 20 min at a flow rate of 1 mL min−1. Detection at 254 nm.
Figure 4Expansion of the 1H[13C] HMBC NMR spectra of compounds A) 5 a and B) 5 c.
Scheme 4PNP‐mediated transglycosylation of flex bases 1, 3 and 5.